AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

13 recruiting trials

for Rejection; Transplant, Liver

Single-center Prospective Study of Non-invasive Methods for the Diagnosis of Postoperative Complications in Liver Transplant Recipients NCT05793203n/a1 site๐Ÿ“ Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS Tissue Analysis of Liver Grafts as a Predictor of Transplant Outcome. NCT06717542NA1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna ยท Tests: histochemical and immunohistochemical analysis, RT-PCR Proteogenomic Monitoring and Assessment of Liver Transplant Recipients NCT01644903n/a1 site๐Ÿ“ Chicago Northwestern University Transcriptomics as an Aid in the Histological Diagnosis of Acute Rejection After Liver Transplantation NCT06734013NA1 site๐Ÿ“ Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna ยท Tests: Molecular diagnostic Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma NCT06254248Phase 210 sites๐Ÿ“ Clichy๐Ÿ“ Crรฉteil๐Ÿ“ Lille Assistance Publique - Hรดpitaux de Paris ยท Tests: Systemic therapy Immune Biomarkers for Predicting Complications After Liver Transplantation NCT07875595n/a3 sites๐Ÿ“ Pilar๐Ÿ“ Buenos Aires๐Ÿ“ Buenos Aires Hospital Italiano de Buenos Aires ยท Tests: Immune Biomarker Assessment Diagnosis of Graft Pathology by TruGraf NCT06557564n/a1 site๐Ÿ“ Toronto University Health Network, Toronto ยท Tests: TruGraf liver gene expression Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues NCT01757730n/a1 site๐Ÿ“ Columbus Arunark Kolipaka MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation NCT06130046n/a1 site๐Ÿ“ Rome University of Rome Tor Vergata ยท Tests: MR-proADM dosage Fibroscan to Guide Post Transplant Immunosuppression Minimization NCT07206277NA1 site๐Ÿ“ Edmonton University of Alberta ยท Tests: Immunosuppression reduction Prospective Study of White Blood Cells NCT04838171n/a1 site๐Ÿ“ London Quell Therapeutics Limited ยท Tests: White blood cell and blood collection Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION) NCT07739914Phase 316 sites๐Ÿ“ Heidelberg๐Ÿ“ Tรผbingen๐Ÿ“ Regensburg Hannover Medical School ยท Tests: Everolimus, Tacrolimus or Cyclosporine CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection NCT07053488Phase 1, Phase 21 site๐Ÿ“ Beijing AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC ยท Tests: Ex Vivo CRISPR-Cas9 Gene Editing of Donor Liver
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy